Silverback Therapeutics, Inc.
USD5.87
+0.06 (+1.03%)
CEO
Peter A. Thompson
IPO Date
2020-12-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.82
Prev. Close
$5.81
Day Low
$5.82
Day High
$6.15
52W Low
$2.80
52W High
$7.54
Market Cap
$0.55B
Volume
0.12M
| 127.9 |
| 31 Dec 2023 | FY | 100.0% | -181216.7% | -23.6% | -23.3% | 0.00 | 96.85 | -9.6 |
| 31 Dec 2022 | FY | -1200.9% | -2635.4% | -12.7% | -12.3% | 0.00 | 51.01 | -9.8 |
| 31 Dec 2021 | FY | 96.1% | -367.7% | 64.7% | -32.9% | -0.29 | 7.42 | -9.5 |
| 31 Dec 2020 | FY | 21.1% | -6.0% | 7.6% | -4.0% | -0.71 | 3.21 | -1509.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 427.8% | -153.2% | -2.79 | 0.59 | -34.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -96.6% | -63.8% | 0.43 | 4.04 | -47.0 |
| -6.9 |
| 30 Sept 2025 | Q3 | 74.8% | -157.4% | -34.6% | -13.7% | 0.01 | 6.66 | -4.9 |
| 30 Jun 2025 | Q2 | 68.3% | -285.6% | -23.3% | -14.3% | 0.01 | 6.17 | -9.6 |
| 31 Mar 2025 | Q1 | 49.3% | -425.7% | -14.8% | -10.4% | 0.00 | 11.00 | -9.1 |
| 31 Dec 2024 | Q4 | 95.5% | 57.7% | 19.4% | 14.2% | 0.00 | 14.26 | 5.2 |
| 30 Sept 2024 | Q3 | 94.6% | -925.0% | -9.5% | -8.8% | 0.00 | 12.56 | -18.4 |
| 30 Jun 2024 | Q2 | 100.0% | -2503.2% | -5.8% | -5.6% | 0.00 | 32.82 | -16.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -4.6% | -4.5% | 0.00 | 60.90 | -22.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -3.1% | -3.1% | 0.00 | 96.85 | -18.4 |